Subscribe
Sign in
Home
Monday March 16, 2026
This week’s signal: neurovascular innovation is accelerating, and the pressure for commercialization readiness is rising — as acquisitions, new funding…
23 hrs ago
•
The Pathway
14
Monday March 9, 2026
Some weeks, the signal is subtle.
Mar 9
•
The Pathway
24
Monday March 2, 2026
If there’s a theme emerging this week, it’s regulatory leverage and capital concentration — FDA decisions and nine-figure financings are separating…
Mar 2
•
The Pathway
19
February 2026
Tuesday February 24, 2026
If there’s a throughline this week, it’s strategic tightening — large strategics consolidating, AI embedding into core platforms, and capital…
Feb 24
•
The Pathway
23
Tuesday February 17, 2026
For those of you in the US, we hope you had a nice President’s Day weekend.
Feb 17
•
The Pathway
9
Monday February 9, 2026
Across regulation, AI adoption, and supply chain strategy, this week’s news highlights how early decisions — and untested assumptions — tend to shape…
Feb 9
•
The Pathway
6
Monday February 2, 2026
This week the trend seems to be execution under scrutiny — from regulators and payers to clinical data and capital markets, med tech leaders are being…
Feb 2
•
The Pathway
20
January 2026
Monday January 26, 2026
If there’s a throughline this week, it’s regulatory tailwinds and ecosystem building — FDA/CE clearances are expanding addressable procedure sets while…
Jan 26
•
The Pathway
60
1
Monday January 19, 2026
Happy Monday, and a fine Dr.
Jan 19
•
The Pathway
6
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts